Skip to main content

Performant Financial Corporation Announces Financial Results for Second Quarter 2021

Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), a leading provider of technology-enabled audit, recovery, and related analytics services in the United States with a focus in the healthcare payment integrity services industry, today reported the following financial results for its second quarter ended June 30, 2021:

Second Quarter Financial Highlights

  • Total revenues of $32.8 million, compared to revenues of $33.8 million in the prior year period.
  • Net loss of approximately $1.5 million, or $(0.03) per diluted share, compared to a net loss of $7.2 million, or $(0.13) per diluted share, in the prior year period.
  • Adjusted net income was $0.5 million, or $0.01 per diluted share, compared to an adjusted net loss of $0.7 million or $(0.01) per diluted share in the prior year period.
  • Adjusted EBITDA of $4.2 million, compared to $4.3 million in the prior year period.

Second Quarter 2021 Results

Total revenues in the second quarter were $32.8 million, a decrease of $0.9 million, or 3% from revenues of $33.8 million in the prior year period. Healthcare revenues in the second quarter of 2021 were $18.6 million, an increase of $4.0 million, or 27%, from revenues of $14.6 million in the prior year period. Within Healthcare, claims-based services revenue in the second quarter of 2021 was $7.0 million, while revenue from eligibility-based services in the second quarter was $11.6 million.

Recovery revenues in the second quarter were $11.1 million, a decrease of $5.1 million, or 31%, from revenues of $16.2 million in the prior year period. Revenues from our Customer Care / Outsourced Services in the second quarter were $3.1 million, an increase of $0.1 million, or 4%, from revenues of $3.0 million in the prior year period.

Net loss for the second quarter was $1.5 million, or $(0.03) per share on a diluted basis, compared to net loss of $7.2 million, or $(0.13) per share on a diluted basis, in the prior year period. Adjusted net income for the second quarter was $0.5 million, or $0.01 per share on a diluted basis, compared to an adjusted net loss of $0.7 million, or $(0.01) per diluted share, in the prior year period. Adjusted EBITDA for the second quarter was $4.2 million as compared to $4.3 million in the prior year period.

As of June 30, 2021, the Company had cash, cash equivalents, and restricted cash of approximately $12.2 million.

Business Commentary and Outlook

“Our decision to transform primarily into a healthcare payment integrity services company, remains on schedule and was reinforced by our results in the second quarter, with healthcare revenues growing by over 27% on a year over year basis,” stated Lisa Im, CEO of Performant.

“We believe there is a tremendous opportunity for us to gain market share and continue to grow within healthcare. However, the recent surge in the Delta variant of COVID-19 provides a bit of uncertainty as it relates to potential slow-downs or pauses in activities in the coming quarters. While we have not seen any impact yet, we are taking a cautious approach in light of the uncertainty, opting to refine our 2021 healthcare revenue guidance to a range of $80 - $85 million while currently continuing to be confident in achieving positive EBITDA results,” continued Im.

Note Regarding Use of Non-GAAP Financial Measures

In this press release, to supplement our consolidated financial statements, the Company presents adjusted EBITDA, adjusted net income (loss), and adjusted net income (loss) per diluted share. These measures are not in accordance with accounting principles generally accepted in the United States of America (US GAAP) and accordingly reconciliations of adjusted EBITDA and adjusted net income (loss) to net income (loss) determined in accordance with US GAAP are included in the “Reconciliation of Non-GAAP Results” table at the end of this press release. We have included adjusted EBITDA and adjusted net income (loss) in this press release because they are key measures used by our management and board of directors to understand and evaluate our core operating performance and trends and to prepare and approve our annual budget. Accordingly, we believe that adjusted EBITDA and adjusted net income (loss) provide useful information to investors and analysts in understanding and evaluating our operating results in the same manner as our management and board of directors. Our use of adjusted EBITDA and adjusted net income (loss) has limitations as an analytical tool and should not be considered in isolation or as a substitute for analysis of our results as reported under US GAAP. In particular, many of the adjustments to our US GAAP financial measures reflect the exclusion of items, specifically interest, tax and depreciation and amortization expenses, equity-based compensation expense and certain other non-operating expenses, that are recurring and will be reflected in our financial results for the foreseeable future. In addition, these measures may be calculated differently from similarly titled non-GAAP financial measures used by other companies, limiting their usefulness for comparison purposes.

Earnings Conference Call

The Company will hold a conference call to discuss its second quarter 2021 results today at 5:00 p.m. Eastern. A live webcast of the call may be accessed on the Investor Relations section of the Company’s website at investors.performantcorp.com. The conference call is also available by dialing 855-327-6837 (domestic) or 631-891-4304 (international).

A replay of the call will be available on the Company's website or by dialing 844-512-2921 (domestic) or 412-317-6671 (international) and entering the passcode 13721981. The telephonic replay will be available approximately three hours after the call, through August 17, 2021.

About Performant Financial Corporation

Performant provides technology-enabled audit, recovery, and analytics services in the United States with a focus in the healthcare payment integrity industry. Performant works with healthcare payers through claims auditing and eligibility-based (also known as coordination-of-benefits) services to identify improper payments. Performant is a leading provider of these services in several industries, including healthcare and government. Performant has been providing recovery audit services for more than ten years to both commercial and government clients, including serving as a Recovery Auditor for the Centers for Medicare and Medicaid Services.

Powered by a proprietary analytic platform and workflow technology, Performant also provides professional services related to the recovery effort, including reporting capabilities, support services, customer care and stakeholder training programs meant to mitigate future instances of improper payments. Founded in 1976, Performant is headquartered in Livermore, California.

Forward Looking Statements

This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding our outlook for revenues, net income (loss), and adjusted EBITDA in 2020 and beyond. These forward-looking statements are based on current expectations, estimates, assumptions and projections that are subject to change and actual results may differ materially from the forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the material adverse impact of the COVID-19 pandemic on our business, results of operations and financial condition as well as on the business operations and financial performance of many of our customers, that the Company may not have sufficient cash flows from operations to fund ongoing operations and other liquidity needs, that the Company’s indebtedness could adversely affect its business and financial condition and could reduce the funds available for other purposes and the failure to comply with covenants contained in its credit agreement could result in an event of default that could adversely affect its results of operations, that the Company faces a long period to implement a new contract which may result in the incurring of expenses before the receipt of revenues from new client relationships, the high level of revenue concentration among the Company's largest customers and any termination in the Company’s relationship with any of our significant clients would result in a material decline in our revenues, that many of the Company's customer contracts are subject to periodic renewal, are not exclusive, do not provide for committed business volumes and may be changed or terminated unilaterally and on short notice, that the Company may not be able to manage its potential growth effectively, that the Company faces significant competition in all of its markets, that continuing limitations on the scope of our audit activity under our RAC contracts have significantly reduced our revenue opportunities with this client, that the U.S. federal government accounts for a significant portion of the Company's revenues, that future legislative and regulatory changes may have significant effects on the Company's business, that failure of the Company's or third parties' operating systems and technology infrastructure could disrupt the operation of the Company's business and the threat of breach of the Company's security measures or failure or unauthorized access to confidential data that the Company possesses. More information on potential factors that could affect the Company's financial condition and operating results is included from time to time in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's annual report on Form 10-K for the year ended December 31, 2020 and subsequently filed reports on Forms 10-Q and 8-K. The forward-looking statements are made as of the date of this press release and the Company does not undertake to update any forward-looking statements to conform these statements to actual results or revised expectations.

PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES

Consolidated Balance Sheets

(In thousands, except per share amounts)

 

June 30,
2021

December 31,
2020

(Unaudited)

Assets

Current assets:

Cash and cash equivalents

$

9,949

$

16,043

Restricted cash

2,203

2,253

Trade accounts receivable, net of allowance for doubtful accounts of $49 and $49, respectively

19,056

23,216

Contract assets

5,770

4,466

Prepaid expenses and other current assets

3,407

3,784

Income tax receivable

5,692

4,758

Total current assets

46,077

54,520

Property, equipment, and leasehold improvements, net

16,005

17,497

Identifiable intangible assets, net

72

689

Goodwill

47,372

47,372

Right-of-use assets

4,028

5,043

Other assets

985

1,106

Total assets

$

114,539

$

126,227

Liabilities and Stockholders’ Equity

Current liabilities:

Current maturities of notes payable to related party, net of unamortized debt issuance costs of $1,001 and $906, respectively

$

8,149

$

59,957

Accrued salaries and benefits

7,727

8,799

Accounts payable

846

407

Other current liabilities

3,511

3,841

Deferred revenue

867

Estimated liability for appeals, disputes, and refunds

4,500

1,014

Lease liabilities

2,207

2,327

Total current liabilities

26,940

77,212

Notes payable to related party, net of current portion and unamortized debt issuance costs of $4,819 and $0, respectively

39,243

Lease liabilities

2,395

3,442

Other liabilities

3,090

3,593

Total liabilities

71,668

84,247

Commitments and contingencies (note 3 and note 4)

Stockholders’ equity:

Common stock, $0.0001 par value. Authorized, 500,000 shares at June 30, 2021 and December 31, 2020 respectively; issued and outstanding 56,401 and 54,764 shares at June 30, 2021 and December 31, 2020, respectively

6

5

Additional paid-in capital

89,784

82,933

Accumulated deficit

(46,919

)

(40,958

)

Total stockholders’ equity

42,871

41,980

Total liabilities and stockholders’ equity

$

114,539

$

126,227

PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES

Consolidated Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

 

Three Months Ended

June 30,

Six Months Ended

June 30,

2021

2020

2021

2020

Revenues

$

32,842

$

33,785

$

64,232

$

79,673

Operating expenses:

Salaries and benefits

23,295

22,166

47,385

50,971

Other operating expenses

10,759

9,042

21,115

21,262

Impairment of goodwill

8,000

27,000

Total operating expenses

34,054

39,208

68,500

99,233

Loss from operations

(1,212

)

(5,423

)

(4,268

)

(19,560

)

Gain on sale of certain recovery contracts

1,849

1,849

Interest expense

(2,126

)

(2,031

)

(3,472

)

(4,258

)

Interest income

6

12

Loss before provision for (benefit from) income taxes

(1,489

)

(7,448

)

(5,891

)

(23,806

)

Provision for (benefit from) income taxes

33

(249

)

70

(4,123

)

Net loss

$

(1,522

)

$

(7,199

)

$

(5,961

)

$

(19,683

)

Net loss per share

Basic

$

(0.03

)

$

(0.13

)

$

(0.11

)

$

(0.36

)

Diluted

$

(0.03

)

$

(0.13

)

$

(0.11

)

$

(0.36

)

Weighted average shares

Basic

55,516

54,267

55,167

54,105

Diluted

55,516

54,267

55,167

54,105

PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

Six Months Ended

June 30,

2021

2020

Cash flows from operating activities:

Net loss

$

(5,961

)

$

(19,683

)

Adjustments to reconcile net loss to net cash provided by operating activities:

Impairment of long-lived assets

674

25

Impairment of goodwill

27,000

Depreciation and amortization

3,040

2,795

Right-of-use assets amortization

1,015

1,275

Stock-based compensation

1,423

1,340

Interest expense from debt issuance costs

1,133

763

Earnout mark-to-market

(162

)

Gain on sale of certain recovery contracts

(1,849

)

Changes in operating assets and liabilities:

Trade accounts receivable

3,417

6,577

Contract assets

(1,304

)

362

Prepaid expenses and other current assets and other assets

564

109

Income tax receivable

(934

)

(1,860

)

Other assets

121

(180

)

Accrued salaries and benefits

(1,072

)

(1,710

)

Accounts payable

439

(1,135

)

Deferred revenue and other current liabilities

(1,147

)

(112

)

Estimated liability for appeals, disputes, and refunds

3,486

197

Lease liabilities

(1,167

)

(1,126

)

Other liabilities

(414

)

1,279

Net cash provided by operating activities

1,464

15,754

Cash flows from investing activities:

Purchase of property, equipment, and leasehold improvements

(1,604

)

(1,943

)

Proceeds from sale of certain recovery contracts

2,406

Net cash provided by (used) in investing activities

802

(1,943

)

Cash flows from financing activities:

Repayment of notes payable

(7,650

)

(1,725

)

Debt issuance costs paid

(150

)

Taxes paid related to net share settlement of stock awards

(633

)

(248

)

Proceeds from exercise of stock options

23

Net cash used in financing activities

(8,410

)

(1,973

)

Net increase (decrease) in cash, cash equivalents and restricted cash

(6,144

)

11,838

Cash, cash equivalents and restricted cash at beginning of period

18,296

4,995

Cash, cash equivalents and restricted cash at end of period

$

12,152

$

16,833

Reconciliation of the Consolidated Statements of Cash Flows to the

Consolidated Balance Sheets:

Cash and cash equivalents

$

9,949

$

15,211

Restricted cash

2,203

1,622

Total cash, cash equivalents and restricted cash at end of period

$

12,152

$

16,833

Non-cash financing activities:

Recognition of earnout shares issued

$

801

$

Recognition of warrants associated with notes payable

$

5,237

$

Supplemental disclosures of cash flow information:

Cash paid for income taxes

$

1,482

$

2,309

Cash paid for interest

$

2,340

$

3,495

PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES

Reconciliation of Non-GAAP Results

(In thousands, except per share amount)

(Unaudited)

 

Three Months Ended

June 30,

Six Months Ended

June 30,

2021

2020

2021

2020

(in thousands)

(in thousands)

Adjusted EBITDA:

Net income (loss)

$

(1,522

)

$

(7,199

)

$

(5,961

)

$

(19,683

)

Provision for (benefit from) income taxes

33

(249

)

70

(4,123

)

Interest expense (1)

2,126

2,031

3,472

4,258

Interest income

(6

)

(12

)

Stock-based compensation

774

649

1,423

1,340

Depreciation and amortization

2,024

1,255

3,040

2,795

Impairment of goodwill (4)

8,000

27,000

Impairment of long-lived assets

636

Earnout mark-to-market (5)

(162

)

(162

)

Severance expenses (6)

1,188

1,496

Non-core operating expenses (7)

1,397

1,908

Gain on sale of certain recovery contracts (8)

(1,849

)

(1,849

)

Adjusted EBITDA

$

4,171

$

4,319

$

4,235

$

11,413

Three Months Ended

June 30,

Six Months Ended

June 30,

2021

2020

2021

2020

(in thousands)

(in thousands)

Adjusted Net Income (Loss):

Net income (loss)

$

(1,522

)

$

(7,199

)

$

(5,961

)

$

(19,683

)

Stock-based compensation

774

649

1,423

1,340

Amortization of intangible assets (2)

558

59

617

118

Amortization of debt issuance costs (3)

764

381

1,133

763

Impairment of goodwill (4)

8,000

27,000

Impairment of long-lived assets

636

Earnout mark-to-market (5)

(162

)

(162

)

Severance expenses (6)

1,188

1,496

Non-core operating expenses (7)

1,397

1,908

Gain on sale of certain recovery contracts (8)

(1,849

)

(1,849

)

Tax adjustments (9)

(779

)

(2,455

)

(1,475

)

(7,991

)

Adjusted net income (loss)

$

531

$

(727

)

$

(2,072

)

$

1,385

Three Months Ended

June 30,

Six Months Ended

June 30,

2021

2020

2021

2020

(in thousands)

(in thousands)

Adjusted Net Income (Loss) Per Diluted Share:

Net income (loss)

$

(1,522

)

$

(7,199

)

$

(5,961

)

$

(19,683

)

Plus: Adjustment items per reconciliation of adjusted net income (loss)

2,053

6,472

3,889

21,068

Adjusted net income (loss)

$

531

$

(727

)

$

(2,072

)

$

1,385

Adjusted net income (loss) per diluted share

$

0.01

$

(0.01

)

$

(0.04

)

$

0.03

Diluted average shares outstanding (10)

60,617

54,267

55,167

54,259

(1)

Represents interest expense and amortization of debt issuance costs related to our Credit Agreement.

(2)

Represents amortization of intangibles related to the acquisition of Performant by an affiliate of Parthenon Capital Partners in 2004.

(3)

Represents amortization of debt issuance costs related to our Credit Agreement.

(4)

Represents a noncash goodwill impairment charge in 2020 mainly due to the decrease of our market capitalization in the first half of 2020.

(5)

Represents the change from prior reporting periods in the fair value of the potential earnout consideration payable to ECMC group in connection with the Premiere acquisition.

(6)

Represents severance expenses incurred in connection with a reduction in force for our non-healthcare recovery services.

(7)

Represents professional fees related to strategic corporate development activities.

(8)

Represents gain on the sale of certain non-healthcare recovery contracts in 2021.

(9)

Represents tax adjustments assuming a marginal tax rate of 27.5% at full profitability.

(10)

While net loss for the three months ended June 30, 2021 is ($1,522), the computation of adjusted net income results in adjusted net income of $531. Therefore, the calculation of the adjusted earnings per diluted share for the three months ended June 30, 2021 includes dilutive common share equivalents of 5,101 added to the basic weighted average shares of 55,516. While net loss for the six months ended June 30, 2020 is ($19,683), the computation of adjusted net income (loss) results in adjusted net income of $1,385. Therefore, the calculation of the adjusted net income per diluted share for the six months ended June 30, 2020 includes dilutive common share equivalents of 154 added to the basic weighted average shares of 54,105.

We are providing the following historical breakdown of the quarterly and annual revenue contributions under the new contribution breakdowns of our healthcare revenue results for the years ended December 31, 2019 and December 31, 2020, and six months ended June 30, 2021:

For the Three Months Ended

For the Year Ended

March 31, 2019

June 30, 2019

September 30, 2019

December 31, 2019

December 31, 2019

(in thousands)

Eligibility-based

$

7,742

$

7,042

$

8,005

$

9,987

$

32,776

Claims-based

1,278

2,221

2,752

4,301

10,552

Healthcare Total

9,020

9,263

10,757

14,288

43,328

Recovery

21,375

22,107

20,936

25,208

89,626

Customer Care / Outsourced Services

4,481

4,460

4,210

4,327

17,478

Total

$

34,876

$

35,830

$

35,903

$

43,823

$

150,432

For the Three Months Ended

For the Year Ended

March 31, 2020

June 30, 2020

September 30, 2020

December 31, 2020

December 31, 2020

(in thousands)

Eligibility-based

$

10,949

$

11,292

$

13,480

$

14,126

$

49,847

Claims-based

6,575

3,301

4,086

4,739

18,701

Healthcare Total

17,524

14,593

17,566

18,865

68,548

Recovery

24,265

16,167

15,443

17,521

73,396

Customer Care / Outsourced Services

4,099

3,025

3,219

3,650

13,993

Total

$

45,888

$

33,785

$

36,228

$

40,036

$

155,937

For the Three Months Ended

For the Six Months Ended

March 31, 2021

June 30, 2021

June 30, 2021

(in thousands)

Eligibility-based

$

7,911

$

11,577

$

19,488

Claims-based

5,375

7,025

12,400

Healthcare Total

13,286

18,602

31,888

Recovery

14,491

11,091

25,582

Customer Care / Outsourced Services

3,613

3,149

6,762

Total

$

31,390

$

32,842

$

64,232

Contacts:

Richard Zubek
Investor Relations
925-960-4988
investors@performantcorp.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.